person
as of 2026-07-01Dean Wong, MD,PhD
Dean Wong, PhD
ORCID 0000-0001-9343-8367
at a glance
Roles: Principal Investigator, Author
KOL signal score 11
2 publications · 1 high-value
Cross-drug reach: 2 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Johns Hopkins University, Baltimore,MD 21287
Roles
Principal Investigator, Author
KOL signal
11
Publications
2 (1 high-value)
Trial investigator
yes
Publishes on
2 drugs
Trials led
2
Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712
NCT00805454Phase 1Completed
Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
NCT04588129Phase 1Completed
Publications & congress
2
Dopamine D
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019 · high-value
PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on